Clinical trial
UX003-EAP
Name
UX003-EAP
Description
Individual patient expanded access requests may be considered for patients who have no other treatment options
Trial arms
Treatment
Mepsevii
Other names:
UX003, recombinant human beta-glucuronidase, rhGUS, vestronidase alfa
Size
-1
Eligibility criteria
Inclusion Criteria:
-
Exclusion Criteria:
-
Protocol
{'studyType': 'EXPANDED_ACCESS', 'nPtrsToThisExpAccNctId': 4, 'expandedAccessTypes': {'individual': True}}
Updated at
2024-03-05
1 organization
1 product
3 indications
Organization
Ultragenyx PharmaceuticalProduct
MepseviiIndication
Mucopolysaccharidosis type VIIIndication
MPS VIIIndication
Sly Syndrome